ERBB2 and breast neoplasm: Here, we use PET/CT tracking to study the biodistribution of 89Zr-labeled human NK (89Zr-NK) cells in mice bearing HER2-positive solid orthotopic HCC1954 human breast tumors and to assess whether administration of HER2-targeted trastuzumab enhances NK cell infiltration into tumors.